GeneDx Holdings Corp. (NASDAQ:WGS) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Second Quarter 2025 Earnings Conference Call.
Genedx Holdings Corp. (WGS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Casdin Capital Eli Casdin | 3,507,164 | $323,746,309 | 29.48% | |
| 2. | Corvex Capital Keith Meister | 3,058,629 | $282,342,043 | +24% | 11.95% |
| 3. | Pentwater Capital Management Matthew Halbower | 1,220,000 | $112,618,200 | +3713% | 0.73% |
| 4. | 1,030,000 | $95,079,300 | +4021% | 0.62% | |
| 5. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 586,100 | $54,102,891 | +29% | 5.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.52 | 24,644 | $1,491,454.88 | 3,058,629 | 2025-05-14 | Filing | |
| $59.81 | 25,356 | $1,516,542.36 | 3,033,985 | 2025-05-14 | Filing | |
| $57.53 | 9,867 | $567,648.51 | 3,008,629 | 2025-05-08 | Filing | |
| $56.96 | 10,897 | $620,693.12 | 2,998,762 | 2025-05-08 | Filing | |
| $55.69 | 79,236 | $4,412,652.84 | 2,987,865 | 2025-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $113.68 | 136 | $15,460.48 | 1,720 | 2025-09-30 | Filing | |
| $111.84 | 645 | $72,134.09 | 1,856 | 2025-09-30 | Filing | |
| $110.23 | 200 | $22,046.00 | 2,501 | 2025-09-30 | Filing | |
| $109.13 | 554 | $60,457.58 | 2,701 | 2025-09-30 | Filing | |
| $108.55 | 5,163 | $560,457.07 | 3,255 | 2025-09-30 | Filing |
Institutional Investors' Holdings
News See All
Guggenheim Raises GeneDx (WGS) Price Target, Maintaining a Buy Rating
Guggenheim analyst Subbu Nambi has raised the price target for GeneDx Holdings Corp (NASDAQ:WGS) from $88.00 to $115.00, reinforcing a bullish stance on the company’s long-term trajectory.
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
“Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s reverberating across Wall Street.
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks to Buy According to Billionaires
US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets.
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
12 High Growth Low Debt Stocks to Invest in Now
The global financial markets are experiencing heightened volatility, influenced by a confluence of economic and geopolitical factors.
12 Best Multibagger Stocks to Buy in 2025
In the world of investing, the term "multibagger" refers to stocks that have the potential to deliver returns several times greater than the original investment.
10 Best Emerging Technology Stocks to Buy Now
The technology sector is constantly evolving, with emerging technology companies leading the charge in groundbreaking innovations.
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center Billionaire Hedge Funds
